Finally, this review highlights CRP’s role in destabilizing vascular tissue via immune signaling, smooth muscle cell activation, and endothelial dysfunction, linking chronic low-grade inflammation to increased arterial vulnerability and eventually plaque instability, especially in patients with diabetes or metabolic syndrome. The gene discussed is CRP; the disease is endothelial dysfunction.